HOME >> BIOLOGY >> NEWS
Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV

strengths of a human adenovirus vaccine without the drawback of pre-existing immunity in its target population.

Because HIV infects only humans and chimpanzees, the current study used a sophisticated mouse model to test the new vaccine. For this model, the researchers first incorporated an internal HIV protein known as gag into the modified chimpanzee adenovirus vaccine. They also engineered a matching vaccine that incorporated gag into the human adenovirus. They then used a variant of the vaccinia virus, which can infect mice, that included the gag protein. For comparison, some mice were exposed to the human adenovirus, so that they would demonstrate the pre-existing immunity to the virus seen in many humans.

After vaccination with the chimpanzee adenovirus vaccine, the mice mounted a powerful T-cell-based immune response and were able to fight off experimental infection by the vaccinia virus containing gag, the HIV protein. The mice pre-exposed to the human adenovirus and vaccinated with the human adenovirus vaccine, however, demonstrated significantly weaker immune responses to the vaccinia virus.

"It's hard to say that because the vaccine works well in a mouse model, it will protect humans from HIV infection," Ertl cautions. "But we do know that the kind of immune response we saw in mice can protect non-human primates infected with SIV from developing disease." SIV, or simian immunodeficiency virus, is the chimpanzee counterpart to HIV, or human immunodeficiency virus.

In addition to moving forward with testing of the chimpanzee adenovirus vaccine against HIV, Ertl and her colleagues are developing similar vaccines against rabies, smallpox, and a number of other viruses.

Julie C. Fitzgerald, a graduate student in senior author Ertl's laboratory, is lead author on the Journal of Immunology study. The other Wistar-based authors are Zhi Q. Xiang, Anthony P. Wlazlo, and Wynetta Giles-Davis. Arturo Reyes-Sandoval is affiliated
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
3-Feb-2003


Page: 1 2 3

Related biology news :

1. Fighting Mycobacterium tuberculosis with structural proteomics
2. Fighting the spread of sudden oak death
3. Fighting the battle of the bulge in children
4. Fighting breast cancer at the molecular level
5. Fighting Fungi
6. Fighting skin cancers with computers and technology
7. Fighting diabetes: UD researchers move closer to chip-based control of smart, implantable insulin pumps
8. Trash From Crop-Processing Plant Harvested For Disease-Fighting Agents
9. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
10. Chemical Contaminants May Inhibit Cancer-Fighting White Blood Cells
11. Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/11/2019)... ... 2019 , ... Greenberg Traurig, LLP attorneys Stephen Baird , ... at DeviceTalks Minnesota, Sept. 9-10, at the Hyatt Regency, Minneapolis. Greenberg Traurig is a ... Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:9/8/2019)... ... September 06, 2019 , ... ... human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of ... and media system designed for product development. RoosterBio continues to simplify MSC ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... As World Mental Health Day ... high school students have improved neuro-cognitive executive skills to enhance learning and academics, ... apply lifelong social/interpersonal, leadership, problem-solving and coping skills, due to an innovative program ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
(Date:10/3/2019)... FAIRFAX, Va. (PRWEB) , ... October 02, 2019 , ... ... the prestigious NHS Digital Health Accelerator run by the East Midlands Academic Health Science ... up the adoption of technology in NHS by providing support to develop and deploy ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as one of ... MRSA becoming one of the most serious concerns. Hong Kong cannot be spared from ... MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the year the ...
Breaking Biology Technology:
Cached News: